The three components of the toxin of Bacillus anthracis, edema factor (EF), protective antigen (PA), and lethal factor (LF), were purified 197-, 156-, and 1,025-fold, with 38, 78, and 11% recovery, respectively. Each purified component was serologically active, distinct, and free from the other components. The purified EF produced edema when mixed with PA, and the purified PA was an active immunogen. The components did not appear to be simple proteins by spectrophotometric analysis. As they were purified, the pH range in which they were most stable narrowed, centering between pH 7.4 and 7.8. Heat readily destroyed the biological activity of the components but not their serological activity. The rat lethality test showed that, with a constant amount of LF and an increasing amount of PA, the time to death reached a minimum and then was extended. When an increasing amount of LF was added to a constant amount of PA, the time to death became shorter as more LF was added. The biological, immunological, and serological properties of the components were shown to vary independently with storage and extent of purification so that serological activity was not always directly correlated with biological activity. Evidence is presented that the components can exist in different molecular configurations or as aggregates, and that this property is influenced by the state of component purity and by the environment.
tivity and interactions observed in the various assay systems are discussed, as well as our interpretation of data on the molecular weight of PA and molecular heterogeneity or aggregation of the whole toxin. A preliminary report of this work has been made (Fish, Bacteriol. Proc., p. 41, 1966) .
MATERIALS AND METHODS
Production of whole toxin. Whole toxin was produced from the Sterne strain of B. anthracis by the procedure of Haines, Klein, and Lincoln (13) .
Biological activity. Edema factor activity was titered in guinea pigs by injecting serial dilutions of EF in PA (33) .
Rat lethality was quantitated by determining the time to death of Fischer 344 rats after intravenous injection (13) . As both PA and LF are required for rat lethality, purification of LF was based entirely on Ouchterlony (serological) analysis.
Serological activity. The double diffusion in agargel (Ouchterlony) method (32) was used to quantitate the serological activity during purification. Equine antiserum (Detrick horse Lot DH-1-6C and Scalvo Lots 76 and 76 AQ, Institute Seraterapico Tuscano, Siena, Italy) was prepared by repeated injections of spores of the Sterne strain of B. anthracis. For all studies on purification, Detrick horse antiserum diluted 1:8 in 0.2% gelatin in saline was used. Antiserum was added to the center wells, and plates were incubated for 6 hr at 30 C; antigen then was added to the outer wells; the plates were reincubated at 30 C for 48 hr, and then were flooded with 0. 1% azocarmine in 0.5 M acetate buffer (pH 4.0) for 3 to 4 hr. The stain was decanted, and the plates were destained by addition of 2% acetic acid for 1 hr. The titer, expressed as units per milliliter was the highest dilution that still yielded a visible line of precipitation (33) . The extent of purification of each component was determined by following the increase in specific activity, which was determined by dividing the Ouchterlony titer by the protein concentration (milligrams per milliliter). When samples were concentrated and reassayed, the Ouchterlony titer was found to yield a linear response.
Immunogenicity of the components. Some of the samples of PA used for this experiment were purified by methods additional to those reported below. The PA (Table 4 , procedure B) that had been isolated after ammonium sulfate precipitation and column chromatography on polyacrylamide (P-2) gel (BioRad Laboratories, Richmond, Calif.) was further treated with alumina C-gamma (C-y) gel (Bio-Rad Laboratories). To 15 ml of the pooled fractions from the P-2 column in a 40-ml centrifuge tube were added 2.3 ml of alumina C-y gel. The tube was incubated at 4 C with occasional stirring for 30 min, and the gel was sedimented by centrifugation at 20,000 X g for 39%, compared with the original culture supernatant fluid. A second treatment with alumina C-y gel resulted in a product purified eightfold and a recovery of 25%. The first and second supernatant fluids were tested for their immunizing ability. The immunity index (I) method of DeArmon et al. (9) was used to determine the degree of immunization. The guinea pigs (Hartley strain, 400 to 500 g) were immunized by five subcutaneous injections of the antigen on alternate days. They were then held for 7 days and challenged intraperitoneally with 103 spores of the virulent Vlb strain of B. anthracis in a l-ml volume of liquid.
Molecular weight determination by columnz chromatography. Sephadex G-75 (Pharmacia, Uppsala, Sweden) was equilibrated and washed with 0.15 M KCI to remove the fines. The material was then equilibrated at 4 C, and a column (3 X 82 cm) was prepared. The following reference samples were used: cytochrome c (A grade) and y-globulin (bovine, fraction II) from Calbiochem, Los Angeles, Calif., pepsin (three times crystallized) from Nutritional Biochemicals Corp., Cleveland, Ohio, and blue dextran 2,000 from Pharmacia. For the molecular weight determination, 1 ml of a 2 mg/ml sample of the standard was carefully layered on top of the column and allowed to absorb into the gel. The column was then eluted with 0.15 M KCI, by use of a flow rate of 1.5 ml/hr. Fractions of 3 ml were collected, and the protein concentration was determined by the ratio of absorption at 215 m,u to that at 225 m, (34) . When the molecular weight of PA was determined, the PA component was assayed by Ouchterlony analysis, as the major protein peak was eluted after about 120 ml of fluid had passed through the column.
Analytical methods and preparation of column materials. Protein was determined spectrophotometrically by the 215/225 mA ratio method of Waddel (34) , with egg albumin and the 260/280 m,u ratio method of Christian and Warburg (7) as standards. Diethylaminoethyl (DEAE) cellulose (Schleicher and Schuell, Keene, N.H.) was washed with 5%' (v/v) HCl in 10% NaCl, followed by 1% NaOH in 10%7 NaCl and then 10%c NaCl to remove any impurities.
NaCl was removed by extensive washing with water, and the DEAE cellulose then was stored under water at 4 C until used. Calcium phosphate gel was prepared according to the method of Main, Wilkins, and Cole (16) .
RESULTS
Whole toxin and its separation into components. Analyses of six lots of whole toxin are presented in Table 1 . The high ratio of dry weight to protein reflects the presence of salts, other culture medium components, and metabolic and soluble bacterial components in the whole toxin preparations. This whole toxin produced edema, was lethal, and was serologically active.
Beall et al. (5) reported that the three major components of anthrax toxin could be separated by selective adsorption and elution from sinteredglass filters. During the first phase of separation, we followed their procedures exactly, and the analysis of these individual components is shown PURIFICATION OF ANTHRAX TOXIN COMPONENTS in Table 2 . Guinea pig edema requires the presence of EF and PA, and rat lethality requires both LF and PA. The isolated components were then further purified by the procedures described below.
Edema factor. The purification of in vitroproduced EF is shown in Table 3 . The eluates from the fine, ultrafine, and two further fine filters were pooled. These pooled filtrates (200 ml) were placed on a column (2.0 x 9.5 cm) of DEAE cellulose, and the eluate was discarded. The EF was eluted with 200 ml of 0.2 M phosphate buffer (pH 7.4) and dialyzed in an ultrafilter (LKB Produkter, Stockholm, Sweden) by removing 73 ml of the solution in four (16 to 23 ml) increments, replacing the volume each time with deionized water. The final preparation was 197-fold purified with respect to the original culture supernatant fluid, and the recovery was 38 %. The original culture supernatant fluid had a guinea pig skin titer of 1:32, and the final purified material had a titer of 1:256. This final material was therefore still active biologically and serologically.
Protective antigen. After the initial separation, PA was purified by three methods which differed mainly in the procedure used for concentrating the culture filtrate.
In the first method (Table 4 , A), 200-ml samples were placed in dialysis tubing and concentrated by pervaporation at 4 C for 7 to 10 days until the volume was reduced to 25 to 35 ml. This material was then chromatographed on a column (2 X 52 cm) of Sephadex G-25 equilibrated and eluted with 0.01 M NaCl. The serological activity appeared in a small protein peak (tubes 30 to 36) that preceded the major protein peak (Fig. 1) . This procedure yielded PA in 90% recovery and 136-fold purification with respect to the original supernatant fluid. a Dry weight of the carbonate eluting buffer was 14.3 mg/ml in some experiments and 28.5 mg/ml in others.
bShown to be contaminated with LF by Ouchterlony analysis.
, Dry weight of the initial medium was 7.5 mg/ ml.
The second method (Table 4 , B) for concentrating PA was by precipitation with ammonium sulfate (30) . PA was precipitated by the addition or solid (NH4)2SO4 until the solution was saturated. Periodic additions of NH40H were necessary to maintain the pH at 7.4 to 7.8. The saturated solution was stirred constantly and held at 4 C for 72 hr to insure complete precipitation. The precipitate was collected by centrifugation at 20,000 x g for 30 min and redissolved in cold water. The PA, in 25-ml amounts, was further purified by chromatography on a column (2 x 52 cm) of polyacrylamide (P-2) gel (Calbiochem) equilibrated and eluted with 0.01 M potassium phosphate buffer (pH 7.4) . This method yielded PA in 78% recovery with 156-fold purification.
The last method tested ( of a UM 1 membrane, which retained components having a molecular weight of 10,000 or greater. The flow rate was approximately 0.5 ml/min, which allowed the processing of large volumes of material in a relatively short time. The concentrated material then was purified by chromatography on polyacrylamide gel (as in method 4 B), and the peak tubes were reconcentrated with the Diaflo cell. PA was obtained with 47% recovery and 64-fold purification. Of the three methods tested, this last method offers the best possibility for future work in purification of large volumes of material (i.e., vaccine production), as it is rapid, economical, and simple. The final preparations of PA were active serologically and biologically, both when combined with EF or LF and as immunogens (10; Fish et al., J. Infect. Diseases, in press). Lethal factor. The results from the purification of LF are given in Table 5 . The carbonate-eluate from the final ultrafine filter was mixed with 31 ml of calcium phosphate gel and allowed to stand for 30 min at 4 C. The gel was removed by centrifugation at 20,000 X g for 5 Serological and biological activity were bothf destroyed by placing the sample in a boiling-water bath for 10 min. The toxin and its components usually were stable after freeze-drying and storage at -20 C, provided that the vials were not allowed to thaw during freeze-drying or to remain on the dryerfor extended periods of time after they were dry. Biological and serological activity were unim--paired by storage of aqueous samples at -20 C.
Chemical stability. The stability of 156-fold purified PA in the presence of various chemical agents is shown in Table 6 . The initial pH of the7 sample was 7.8, and the pH range of the various mixtures was 6.8 to 8.1. PA appeared to be relatively stable in the presence of all reagentstested except for the hydrogen bond-disrupting, reagents, urea and guanidine acetate, and thesurface-active agent, sodium lauryl sulfate.
Crude PA, after the final filtration step, wasrelatively stable in both oxidizing reagents (0.15 % potassium ferricyanide and 0.05% potassium iodate) and reducing reagents (0.1% cysteine).
LF (Table 7) was not particularly sensitive toeither oxidizing or reducing reagents. It was more stable than PA in the presence of hydrogen bonddisrupting reagents. In contrast to PA, it was relatively stable in the presence of sodium lauryl sulfate. The initial pH of the sample was 9.7, and the various mixtures had a pH range of 8.7 to 9.5.
Crude preparations of EF, 35-fold purified, were stable in the presence of 0.1 % cysteine and 0.05% potassium iodate but were unstable in the presence of 0.15 % potassium ferricyanide. These Antiserum binding. The ability of antiserum to bind toxin in vitro was determined. An identical amount of antigen was added to twofold serial dilutions of the antiserum; the mixture was kept at room temperature for 15 min, and then samples were placed in the outer row of wells. The inner wells contained a 1:8 dilution of the antiserum. The highest dilution of antiserum that prevented the formation of a line of precipitation indicated its binding ability. Table 8 shows that the binding observed was concentration-dependent and that 1 ml of undiluted antiserum bound Table 9 . They show that the amount of LF and PA needed for lethality was a function of both components. The results also show that the time to death reached a minimum, and then, with the addition of more PA, there was some extension in the time to death. This observation parallels that of Molnar and Altenbern (17) . The minimal lethal amounts of PA and LF were 32:4 or 16:8. When PA was kept constant and the amount of LF was varied, the time to death became shorter as the amount of LF present increased (Table 9) .
Immunogenicity. The capability of our preparation of PA, in various stages of purification, to protect guinea pigs against challenge with a lethal dose of virulent spores was tested. The results (Table 10) show that PA, in all stages of purification, was a good immunogen. The more purified material appeared to be an even better immunogen than the cruder material, as evidenced by an increased immunity index (3.5 to 5.0) with a decreased amount of protein (1.47 to 0.01 mg) or Ouchterlony units (20 to 8) injected.
Molecular weight and molecular heterogeneity. Allison and Humphrey (1) proposed a method for approximating the molecular weight of antigens based on their ability to migrate through various concentrations of agar. Both PA (after final filtration) and LF purified 35-fold migrated through 1 to 9% agar, indicating that their molecular weight was less than about 400,000 The presence of multiple lines of precipitation in these high concentrations of agar from purified samples which showed only one line of precipitation under standard conditions of Ouchterlony analysis indicated the presence either of aggregates of various sizes of the individual components or of extraneous antigens that were not detectable under the previous assay conditions. A comparison of the elution volume after column chromatography on Sephadex has yielded a reasonably reliable value for the molecular weight of many proteins (2) . A composite elution diagram from a Sephadex G-75 column of several proteins whose molecular weight is known is shown in Fig. 3 . The PA preparation used for this determination was a sample that had been concentrated in the Diaflo (Amicon Corp.) ultrafiltration cell, purified 64-fold. The indicated molecular weight of PA was between 35,000 and 171,000, and appeared to be about 100,000.
During purification of PA and LF, when desalting on Sephadex G-25, both components were eluted near the void volume of the column, indicating a molecular weight greater than 10,000.
During the purification of the toxin components, the lines of precipitation corresponding to LF and EF occasionally showed partial identity but always were distinct from PA. When PA preparations that had been concentrated by pervaporation or by ammonium sulfate precipitation and still contained a rather high concen-GAMMA GLOBULIN 171,000 tration of ammonium sulfate were stored at 4 C for as long as 60 days, not only did the titers decrease but several additional lines appeared, forming closer to the antigen well. These lines were still serologically distinct from LF and EF, and could represent PA aggregates of different molecular weight. Recently, Winstead and Wold (35) showed that rabbit muscleenolase dissociated reversibly in the presence of ammonium sulfate and that it underwent "a concentration-dependent association to higher molecular weight asymmetrical aggregates." Upon chromatography of either PA or LF on Sephadex G-25, we occasionally observed the presence of multiple peaks that were still antigenically distinct from the other two major components of toxin. These most likely represent aggregates of different molecular weights.
DISCUSSION
The three components of anthrax toxin have been purified from both in vivo (23, 25, 26) and in vitro (5, 14, 24, 27, 29, 33) sources. Although the assay methods have differed from one research group to another, certain generalizations have been made about the state of purity of the various components (10). The procedures described here yielded the three separated components in a more highly purified state than any method in the literature to date. The purified EF was free from both LF and PA, and when mixed with PA produced an edema in guinea pigs. The purified PA was serologically distinct from the other two components and was an active immunogen. However, the identification of PA solely on the basis of its ability to protect animals against spore challenge is dangerous. For example, the PA used by Gladstone (12) , Wright, Hedberg, and Slein (36) , and Boor and Tresselt (6) was almost certainly the complete toxin, since either serum, which prevents the retention of the components on the filter (5, 33), was added at some stage either of production or of processing, or the pH was raised to 8.7, which could prevent EF or LF from being adsorbed. In our procedure, based on the observations of Beall et al. (5) , a pH of 9.3 eluted these components from the filter.
A second danger in characterizing PA solely by its ability to protect animals against spore challenge was shown by Mahlandt et al. (15) , who observed (i) that immunization with LF protected rats against either toxin or spore challenge and guinea pigs against spore challenge, (ii) that PA protected both species against spore challenge but neither against toxin challenge, and (iii) that EF had an additive effect in certain combinations.
In this discussion, literature references to toxin produced both in vivo and in vitro, and its components, are included. Sargeant et al. (18) found several serological differences between toxin produced in vivo and in vitro and so the reader is reminded, again, that all our work was done with in vitro-produced toxin and that the two types of toxin may or may not be similar in their composition or in any specific response.
The exact chemical composition of the toxin components is unknown. Smith (20) , working with in vivo-produced toxin that was later shown to be heavily contaminated with guinea pig serum components (26) , stated that factor I (EF) was a lipoprotein containing carbohydrate residues, and that factor II (PA) was a protein. On the basis of its chemical composition, factor III (LF) also was reported to be a protein (24) . Although EF appeared to be contaminated with 6 to 8% nucleic acid, based on its absorption at 260 m,u, the presence of ribonucleic acid or deoxyribonucleic acid could not be demonstrated (27) . Strange and Thorne (30) showed that purified PA had the ultraviolet absorption spectrum of a typical protein. Our spectrophotometric results indicated that none of the purified components was pure protein; rather, all appeared to contain from 3 to 5% nucleic acid or some other base, which accounted for their absorption maximum at 270 (18, 24) , there is general agreement that all of the components are extremely sensitive to heat (20, 26, 27, 33) . The assay system is especially important, because serological activity is not always a good criterion for determining biological or immunological activity (18) .
We have not been able to maintain consistently either the biological or the serological activity of EF during freeze-drying or storage at 4 or -20 C. The most stable preparation was an ammonium sulfate precipitate stored at 4 C. We have found that carefully controlled freeze-drying of the whole toxin, PA or LF, yields products that retain their biological and serological activity after 2 years of storage at -20 C. Again, as in the case of pH stability, the effect of temperature depends on the concentration and purification of the components.
Results from Ouchterlony analyses must be interpreted carefully. Although Thorne and Belton (32) obtained a good correlation between Ouchterlony titer and immunizing ability, Smith (19) and Beall, Taylor, and Thorne (5) pointed out that the toxin components readily lost toxicity but retained their serological activity. Molnar and Altenbem (17) found that two of four preparations of PA were unable to form a lethal mixture when combined with LF, but were serologically indistinguishable from active PA. We often observed that biological activity was lost prior to loss of serological activity. The serological relationship among these components indicates that they could, at some time, have shared a common form or architecture, although EF and LF appear to be much more closely related to each other than to PA.
Sargeant et al. (18) concluded that there were at least three distinct serological components in toxin produced both in vivo and in vitro, although minor differences were found between the in vivo and in vitro toxin. They also demonstrated the presence of biologically inactive but serologically active factor II (PA) in some preparations of factor I (EF). Separation of what had appeared to be one line of precipitation into two lines occurred during heat-inactivation studies. We found that, although we could clearly distinguish among the three purified components when they were placed in adjacent wells, it was often difficult to identify the three components when mixed. PA always seemed to be serologically distinct from both EF and LF, but, during various stages in their purification, EF and LF often showed partial identity or at least some sort of interaction. In addition, storage of protective antigen resulted in the appearance of new lines of precipitation without loss of biological activity. These observations indicate the ease with which these components may aggregate or polymerize or be degraded. Similar results have been obtained with in vivo-produced toxin (11).
Molnar and Altenbern (17) pointed out that injection of PA into animals that had been injected with a lethal dose of toxin could considerably extend their time to death. They, therefore, stated that protective antigen was the site of attachment of the toxin to the tissue. Our results, obtained by adding an increasing amount of PA to a constant amount of LF, verify their work, but their explanation is probably too simple because increasing amounts of LF added to a constant amount of PA decrease the time to death, and the addition of more PA to a constant amount of whole toxin also decreases time to death. We again feel that not enough consideration has been given to the ability of these components to exist in different aggregate states and also in different degrees of activity (i.e., biological, serological, immunological). Molnar and Altenbern, themselves, speculate that PA undergoes some subtle physiochemical changes rather than extensive splitting of the molecule. The PA studied by Strange and Thorne (30) and Wright and Luksas (Federation Proc. 23:191, 1964 ) was composed of more than one molecule. The English workers (21, 25, 26) have repea.edly reporied that EF disassociates and reaggregates with the slightest treatment. Stanley and Smith (27) reported the chelating action of EF and speculated that the whole toxin might have existed as a loose complex.
These data from the literature and our results reported here and elsewhere (10, 11; Fish et al.,  in press) all indicate that the toxin components, and the whole toxin itself, exist as different molecular complexes whose biological, immunological, and serological activities are greatly affected by or related to their degree of purity and immediate environment.
Use of these purified components and knowledge of their configuration will allow more critical studies to be undertaken to characterize the toxin and to determine the pathophysiological changes that it induces in the host. The use of defined materials will also result in more uniformity of results among workers.
